

          1. Patient currently hospitalized or under immediate consideration for hospitalization;

          2. Patient currently in shock or with hemodynamic instability;

          3. Patient with inflammatory bowel disease (Crohn's disease or ulcerative colitis),
             chronic diarrhea or malabsorption;

          4. Patient with pre-existent progressive neuromuscular disease;

          5. Estimated Glomerular filtration rate (eGFR), using the MDRD equation for all subjects
             being considered for enrollment, with a cut-off of < 30 mL/m in/1.73m2;

          6. Patient with a history of cirrhosis, chronic active hepatitis or severe hepatic
             disease;

          7. Female patient who is pregnant, or breast-feeding or is considering becoming pregnant
             during the study or for 6 months after the last dose of study medication;

          8. Patient currently taking colchicine for other indications (mainly chronic indications
             represented by Familial Mediterranean Fever or gout);

          9. Patient with a history of an allergic reaction or significant sensitivity to
             colchicine;

         10. Patient undergoing chemotherapy for cancer;

         11. Patient is considered by the investigator, for any reason, to be an unsuitable
             candidate for the study.
      